Analysts' Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), Biogen (BIIB) and Sartorius (GB:0NIR)
Starbucks Stock (NASDAQ:SBUX) Looks Intriguing After Venti-Sized Sell-Off
Kraft Heinz Analyst Ratings
Mondelez International Analyst Ratings
Citigroup Cuts Price Target on Starbucks to $80 From $85
PepsiCo Analyst Ratings
Barclays Maintains Overweight on PepsiCo, Raises Price Target to $187
BofA Securities Raises Price Target on Warner Bros. Discovery to $14 From $12, Maintains Buy Rating
Barclays Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $37
Keurig Dr Pepper Analyst Ratings
Coca-Cola Europacific Analyst Ratings
Marriott Intl Analyst Ratings
CrowdStrike Holdings Analyst Ratings
Starbucks Analyst Ratings
Jefferies Adjusts Cintas Price Target to $730 From $665
Charter Communications Analyst Ratings
Cintas (CTAS) Receives a Rating Update From a Top Analyst
UBS Adjusts MercadoLibre Price Target to $2,000 From $1,950, Maintains Buy Rating
BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $566 From $500
BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,300 From $1,082, Outperform Rating Maintained